Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. (Q44907080)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. |
scientific article |
Statements
1 reference
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. (English)
1 reference
Eugene V McCloskey
1 reference
Anders Oden
1 reference
John A Kanis
1 reference
Roman Lorenc
1 reference
E Michael Lewiecki
1 reference
Helena Johansson
1 reference
Cesar Libanati
1 reference
Matt Austin
1 reference
Ethel Siris
1 reference
Andrea Wang
1 reference
1 July 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference